82 FR 17269 - National Heart, Lung, and Blood Institute; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 67 (April 10, 2017)

Page Range		17269-17269
FR Document		2017-07056

Federal Register, Volume 82 Issue 67 (Monday, April 10, 2017)

[Federal Register Volume 82, Number 67 (Monday, April 10, 2017)]
[Notices]
[Page 17269]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-07056]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Sleep Disorders Research Advisory Board.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Sleep Disorders Research Advisory Board.
    Date: June 22-23, 2017.
    Time: June 22, 2017, 1:00 p.m. to 5:00 p.m.
    Agenda: Update on NIH sleep disorders research programs and 
initiatives, updates on sleep related activities from selected 
Federal Agency partners, and discussion of the NIH Sleep Disorders 
Research Plan.
    Place: National Institutes of Health, Two Rockledge Center, 
Conference Room 9100/9104, 6701 Rockledge Drive, Bethesda, MD 20892.
    Time: June 23, 2017, 8:00 a.m. to 3:00 p.m.
    Agenda: Discussion and updates on the NIH Sleep Disorders 
Research Plan, and potential directions for inter-agency 
coordination activities.
    Place: National Institutes of Health, Two Rockledge Center, 
Conference Room 9100/9104, 6701 Rockledge Drive, Bethesda, MD 20892.
    Contact Person: Michael J. Twery, Ph.D., Director, National 
Center on Sleep Disorders Research, Division of Lung Diseases, 
National Heart, Lung, and Blood Institute, National Institutes of 
Health, 6701 Rockledge Drive, Suite 10170, Bethesda, MD 20892-7952, 
301-435-0199, [email protected].
    Information is also available on the Institute's/Center's home 
page: https://www.nhlbi.nih.gov/about/committees/sdrab/, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)


    Dated: April 4, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07056 Filed 4-7-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 67 / Monday, April 10, 2017 / Notices 17269

Infectious Diseases, 5601 Fishers Lane, Patent Application No. 62/153,654 filed DEPARTMENT OF HEALTH AND
Rockville, MD 20852; tel. 301–496– April 28, 2015; PCT Patent Application HUMAN SERVICES
2644. A signed Confidential Disclosure No. PCT/US2016/029673 filed April 28,
Agreement will be required to receive 2016. National Institutes of Health
copies of unpublished patent
Licensing Contact: James M. National Heart, Lung, and Blood
applications.
Robinson, 301–761–7542; Institute; Notice of Meeting
SUPPLEMENTARY INFORMATION: James.Robinson4@nih.gov.
Technology descriptions follows. Pursuant to section 10(a) of the
Collaborative Research Opportunity:
Compositions and Methods for The Technology Transfer and Federal Advisory Committee Act, as
Detecting Loa Loa Intellectual Property Office (TTIPO) is amended (5 U.S.C. App.), notice is
Description of Technology: Loa loa is seeking parties interested in hereby given of a meeting of the Sleep
a filarial nematode estimated to infect collaborative research to further Disorders Research Advisory Board.
3–13 million people in Central and develop, evaluate or commercialize a The meeting will be open to the
Western Africa. In parts of Africa, mass diagnostic means for detecting Loa loa public, with attendance limited to space
administration of ivermectin is common microfilaria-specific antigens. For available. Individuals who plan to
for onchocerciasis and lymphatic collaboration opportunities, please attend and need special assistance, such
filariasis control. However, some contact James M. Robinson, 301–761– as sign language interpretation or other
individuals infected with Loa loa 7542; James.Robinson4@nih.gov. reasonable accommodations, should
microfilariae in high densities are notify the Contact Person listed below
known to experience post-ivermectin Dated: March 28, 2017. in advance of the meeting.
severe adverse events, such as Suzanne Frisbie,
Name of Committee: Sleep Disorders
encephalopathy, coma, or even death. Deputy Director, Technology Transfer and Research Advisory Board.
Therefore, diagnostic tools that can Intellectual Property Office, National Institute Date: June 22–23, 2017.
accurately identify and differentiate Loa of Allergy and Infectious Diseases. Time: June 22, 2017, 1:00 p.m. to 5:00 p.m.
loa microfilariae from other filarial [FR Doc. 2017–07058 Filed 4–7–17; 8:45 am] Agenda: Update on NIH sleep disorders
infections are needed. Microscopic BILLING CODE 4140–01–P research programs and initiatives, updates on
evaluation of blood samples is the only sleep related activities from selected Federal
current diagnostic method used to Agency partners, and discussion of the NIH
detect Loa loa microfilaremia in DEPARTMENT OF HEALTH AND Sleep Disorders Research Plan.
endemic areas, and is impractical for HUMAN SERVICES Place: National Institutes of Health, Two
widespread screening. Molecular based Rockledge Center, Conference Room 9100/
assays are useful and are quantitative, National Institutes of Health 9104, 6701 Rockledge Drive, Bethesda, MD
but require the use of sophisticated 20892.
instrumentation. Office of the Director; Notice of Charter Time: June 23, 2017, 8:00 a.m. to 3:00 p.m.
The inventors analyzed samples from Renewal Agenda: Discussion and updates on the
Loa loa infected patients and uninfected NIH Sleep Disorders Research Plan, and
potential directions for inter-agency
controls, and have identified Loa loa In accordance with Title 41 of the
coordination activities.
microfilaria-specific antigens. The U.S. Code of Federal Regulations, Place: National Institutes of Health, Two
pending application claims a variety of Section 102–3.65(a), notice is hereby Rockledge Center, Conference Room 9100/
means of detecting these antigens. given that the Charter for the Center for 9104, 6701 Rockledge Drive, Bethesda, MD
This technology is available for Scientific Review Advisory Council 20892.
licensing for commercial development (CSRAC) was renewed for an additional Contact Person: Michael J. Twery, Ph.D.,
in accordance with 35 U.S.C. 209 and 37 two-year period on March 31, 2017. Director, National Center on Sleep Disorders
CFR part 404, as well as for further Research, Division of Lung Diseases, National
development and evaluation under a It is determined that the CSRAC is in
Heart, Lung, and Blood Institute, National
research collaboration. the public interest in connection with Institutes of Health, 6701 Rockledge Drive,
Potential Commercial Applications: the performance of duties imposed on Suite 10170, Bethesda, MD 20892–7952, 301–
• Diagnostics the National Institutes of Health by law, 435–0199, twerym@nhlbi.nih.gov.
Competitive Advantages: and that these duties can best be Information is also available on the
• Highly specific to Loa loa performed through the advice and Institute’s/Center’s home page: https://
microfilariae counsel of this group. www.nhlbi.nih.gov/about/committees/sdrab/,
• Highly sensitive Inquiries may be directed to Jennifer
where an agenda and any additional
• Both diagnostic and quantitative information for the meeting will be posted
• Works with blood, urine, or saliva Spaeth, Director, Office of Federal when available.
sample Advisory Committee Policy, Office of (Catalogue of Federal Domestic Assistance
Development Stage: the Director, National Institutes of Program Nos. 93.233, National Center for
• Pre-Clinical Health, 6701 Democracy Boulevard, Sleep Disorders Research; 93.837, Heart and
Inventors: Thomas B. Nutman, NIAID, Suite 1000, Bethesda, Maryland 20892 Vascular Diseases Research; 93.838, Lung
NIH; Sasisekhar Bennuru, NIAID, NIH; (Mail Code 4875), Telephone (301) 496– Diseases Research; 93.839, Blood Diseases
2123, or spaethj@od.nih.gov. and Resources Research, National Institutes
asabaliauskas on DSK3SPTVN1PROD with NOTICES

and Papa Makhtar Drame, NIAID, NIH.
Publications: Drame, Papa, et al. 2016. of Health, HHS)
Dated: April 4, 2017.
Identification and Validation of Loa loa
Michelle Trout, Dated: April 4, 2017.
Microfilaria-Specific Biomarkers: A
Rational Design Approach Using Program Analyst, Office of Federal Advisory Michelle Trout,
Proteomics and Novel Immunoassays. Committee Policy. Program Analyst, Office of Federal Advisory
mBio, vol. 7 no. 1 e02132–15. [FR Doc. 2017–07054 Filed 4–7–17; 8:45 am] Committee Policy.
Intellectual Property: HHS Reference BILLING CODE 4140–01–P [FR Doc. 2017–07056 Filed 4–7–17; 8:45 am]
No. E–140–2015/0—US Provisional BILLING CODE 4140–01–P

VerDate Sep<11>2014 20:02 Apr 07, 2017 Jkt 241001 PO 00000 Frm 00092 Fmt 4703 Sfmt 9990 E:\FR\FM\10APN1.SGM 10APN1

Document Created: 2017-04-08 03:30:47
Document Modified: 2017-04-08 03:30:47

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 22-23, 2017.
FR Citation		82 FR 17269

82 FR 17269 - National Heart, Lung, and Blood Institute; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 67 (April 10, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health